Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effects of empagliflozin on left ventricular diastolic function in adults with type 2 diabetes and diastolic dysfunction; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Diabetes Mellitus, Type 2, Diastolic Dysfunction | Phase 4 | Status: COMPLETED